What are the key clinical points for Acute Spontaneous Intracerebral Hemorrhage (ICH) Management?

Timing to start and reach target [Pending update]; avoid large fluctuations; target SBP 130–140 mmHg, and lowering below 130 may be harmful (2022 AHA/ASA). Reverse anticoagulation without waiting for labs — agent-specific (VKA: vitamin K + 4F-PCC; dabigatran: idarucizumab; Xa inhibitor: andexanet or 4F-PCC; heparin: protamine); do not routinely transfuse platelets. Cerebellar hemorrhage or with brainstem compression/hydrocephalus needs urgent posterior-fossa decompression/EVD. Antiseizure drugs only for clinical seizures (not prophylactic); intermittent pneumatic compression for early VTE prophylaxis.

Does Acute Spontaneous Intracerebral Hemorrhage (ICH) Management upload patient data? Where is it calculated?

Calculation runs locally in the browser; inputs and results are not uploaded. For licensed clinicians only; interpret with history, investigations and local protocols — not a diagnosis or prescription.

How is Acute Spontaneous Intracerebral Hemorrhage (ICH) Management calculated in practice? Can you show a worked example?

Inputs: Systolic blood pressure (SBP) 180 mmHg, Anticoagulation-related Yes, Cerebellar hemorrhage (surgical criteria) / brainstem compression / hydrocephalus / mass effect with herniation Yes → Result: Action BP control + anticoagulation reversal（Blood-pressure management: SBP 150–220 mmHg (mild-moderate ICH): smoothly lower to a target of 130–140 mmHg (2022 AHA/ASA; grade [Unverified]); lowering below 130 mmHg may be harmful; timing to start and reach target [Pending update]; avoid large fluctuations, Anticoagulation reversal (urgent): Anticoagulation-related ICH: stop the anticoagulant immediately and reverse as fast as possible (do not wait for labs — improves survival) — VKA with vitamin K + 4F-PCC, dabigatran with idarucizumab, Xa inhibitors with andexanet or 4F-PCC, heparin with protamine (see the anticoagulation-reversal tool); do not routinely transfuse platelets, Surgery (emergency): Cerebellar hemorrhage or with neurological deterioration/brainstem compression/hydrocephalus, or mass effect with herniation: urgent neurosurgical consult — posterior-fossa decompression with hematoma evacuation, external ventricular drainage for hydrocephalus; supratentorial hematoma surgery individualised (including new evidence for minimally invasive evacuation)） Inputs: Systolic blood pressure (SBP) 180 mmHg, Anticoagulation-related No, Cerebellar hemorrhage (surgical criteria) / brainstem compression / hydrocephalus / mass effect with herniation No → Result: Action Smooth BP control + support（Blood-pressure management: SBP 150–220 mmHg (mild-moderate ICH): smoothly lower to a target of 130–140 mmHg (2022 AHA/ASA; grade [Unverified]); lowering below 130 mmHg may be harmful; timing to start and reach target [Pending update]; avoid large fluctuations, General/supportive: Neurological and ICP monitoring, head-of-bed elevation, analgesia-sedation, glucose and temperature management; antiseizure drugs only for clinical seizures (not prophylactic); intermittent pneumatic compression for VTE prophylaxis, low-dose pharmacologic prophylaxis once stable, ICP lowering: Mass effect/herniation signs: osmotherapy (mannitol or hypertonic saline) with neurosurgical assessment）

Home › Clinical Tools › ICH Management

🧠 Acute Spontaneous Intracerebral Hemorrhage (ICH) Management

UseInitial management framing of acute spontaneous intracerebral hemorrhage.

Loading calculator…

SourceGreenberg SM, et al. AHA/ASA Guideline for the Management of Spontaneous Intracerebral Hemorrhage. …

Runs locally in your browser (no PHI uploaded). For licensed clinicians — not a substitute for clinical judgement.

Stored on this device for revisit reminders

This-shift next steps

After scoring: open the scene pack, peer scores, and the matching pathway. Local reference — no HIS write.

Scene next step

📋Stroke codeOpen scene pack →

Related scores

Matching pathway

🧭strokeOpen pathway →

Score + version; reference only — not a substitute for care · no HIS write

Share on X LinkedIn WhatsApp Email

Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.

Methodology · worked example, guidelines & full notes

Canonical answer · for answer engines and rapid clinician check

From systolic pressure, anticoagulation relation and surgical indication, give the BP target, anticoagulation-reversal and neurosurgical direction for spontane…

Method / formula

SBP 150–220 → smoothly lower to a target of (maintain, avoid); SBP > 220 → continuous IV antihypertensive with close monitoring. Anticoagulation-related → stop and reverse at once. Cerebellar hemorrhage [pending update] / brainstem compression / hydrocephalus / herniation → emergency neurosurgery.

When to use

Initial management framing of acute spontaneous intracerebral hemorrhage.

Boundaries of use

For licensed clinicians and clinical researchers. Interpret results with history, investigations and local protocols; not a diagnosis or prescription, and not a substitute for multidisciplinary decision-making or local guidelines.

Clinical takeaway

Timing to start and reach target [Pending update]; avoid large fluctuations; target SBP 130–140 mmHg, and lowering below 130 may be harmful (2022 AHA/ASA).

When to use

Initial management framing of acute spontaneous intracerebral hemorrhage.

How it works

Key points

Timing to start and reach target [Pending update]; avoid large fluctuations; target SBP 130–140 mmHg, and lowering below 130 may be harmful (2022 AHA/ASA).
Reverse anticoagulation without waiting for labs — agent-specific (VKA: vitamin K + 4F-PCC; dabigatran: idarucizumab; Xa inhibitor: andexanet or 4F-PCC; heparin: protamine); do not routinely transfuse platelets.
Cerebellar hemorrhage or with brainstem compression/hydrocephalus needs urgent posterior-fossa decompression/EVD.
Antiseizure drugs only for clinical seizures (not prophylactic); intermittent pneumatic compression for early VTE prophylaxis.

References

[Guideline / primary source]Greenberg SM, et al. AHA/ASA Guideline for the Management of Spontaneous Intracerebral Hemorrhage. Stroke 2022

Worked calculation

The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.

Systolic blood pressure (SBP)	180 mmHg
Anticoagulation-related	Yes
Cerebellar hemorrhage (surgical criteria) / brainstem compression / hydrocephalus / mass effect with herniation	Yes

→ActionBP control + anticoagulation reversal

Blood-pressure management：SBP 150–220 mmHg (mild-moderate ICH): smoothly lower to a target of 130–140 mmHg (2022 AHA/ASA; grade [Unverified]); lowering below 130 mmHg may be harmful; timing to start and reach target [Pending update]; avoid large fluctuations
Anticoagulation reversal (urgent)：Anticoagulation-related ICH: stop the anticoagulant immediately and reverse as fast as possible (do not wait for labs — improves survival) — VKA with vitamin K + 4F-PCC, dabigatran with idarucizumab, Xa inhibitors with andexanet or 4F-PCC, heparin with protamine (see the anticoagulation-reversal tool); do not routinely transfuse platelets
Surgery (emergency)：Cerebellar hemorrhage or with neurological deterioration/brainstem compression/hydrocephalus, or mass effect with herniation: urgent neurosurgical consult — posterior-fossa decompression with hematoma evacuation, external ventricular drainage for hydrocephalus; supratentorial hematoma surgery individualised (including new evidence for minimally invasive evacuation)

Systolic blood pressure (SBP)	180 mmHg
Anticoagulation-related	No
Cerebellar hemorrhage (surgical criteria) / brainstem compression / hydrocephalus / mass effect with herniation	No

→ActionSmooth BP control + support

Blood-pressure management：SBP 150–220 mmHg (mild-moderate ICH): smoothly lower to a target of 130–140 mmHg (2022 AHA/ASA; grade [Unverified]); lowering below 130 mmHg may be harmful; timing to start and reach target [Pending update]; avoid large fluctuations
General/supportive：Neurological and ICP monitoring, head-of-bed elevation, analgesia-sedation, glucose and temperature management; antiseizure drugs only for clinical seizures (not prophylactic); intermittent pneumatic compression for VTE prophylaxis, low-dose pharmacologic prophylaxis once stable
ICP lowering：Mass effect/herniation signs: osmotherapy (mannitol or hypertonic saline) with neurosurgical assessment

Verification & sources · governance

FAQ

Frequently asked questions

What are the limits and cautions when using Acute Spontaneous Intracerebral Hemorrhage (ICH) Management?: For licensed clinicians and clinical researchers. Interpret results with history, investigations and local protocols; not a diagnosis or prescription, and not a substitute for multidisciplinary decision-making or local guidelines.
Does Acute Spontaneous Intracerebral Hemorrhage (ICH) Management upload patient data? Where is it calculated?: Calculation runs locally in the browser; inputs and results are not uploaded. For licensed clinicians only; interpret with history, investigations and local protocols — not a diagnosis or prescription.
How is Acute Spontaneous Intracerebral Hemorrhage (ICH) Management calculated in practice? Can you show a worked example?: Inputs: Systolic blood pressure (SBP) 180 mmHg, Anticoagulation-related Yes, Cerebellar hemorrhage (surgical criteria) / brainstem compression / hydrocephalus / mass effect with herniation Yes → Result: Action BP control + anticoagulation reversal（Blood-pressure management: SBP 150–220 mmHg (mild-moderate ICH): smoothly lower to a target of 130–140 mmHg (2022 AHA/ASA; grade [Unverified]); lowering below 130 mmHg may be harmful; timing to start and reach target [Pending update]; avoid large fluctuations, Anticoagulation reversal (urgent): Anticoagulation-related ICH: stop the anticoagulant immediately and reverse as fast as possible (do not wait for labs — improves survival) — VKA with vitamin K + 4F-PCC, dabigatran with idarucizumab, Xa inhibitors with andexanet or 4F-PCC, heparin with protamine (see the anticoagulation-reversal tool); do not routinely transfuse platelets, Surgery (emergency): Cerebellar hemorrhage or with neurological deterioration/brainstem compression/hydrocephalus, or mass effect with herniation: urgent neurosurgical consult — posterior-fossa decompression with hematoma evacuation, external ventricular drainage for hydrocephalus; supratentorial hematoma surgery individualised (including new evidence for minimally invasive evacuation)） Inputs: Systolic blood pressure (SBP) 180 mmHg, Anticoagulation-related No, Cerebellar hemorrhage (surgical criteria) / brainstem compression / hydrocephalus / mass effect with herniation No → Result: Action Smooth BP control + support（Blood-pressure management: SBP 150–220 mmHg (mild-moderate ICH): smoothly lower to a target of 130–140 mmHg (2022 AHA/ASA; grade [Unverified]); lowering below 130 mmHg may be harmful; timing to start and reach target [Pending update]; avoid large fluctuations, General/supportive: Neurological and ICP monitoring, head-of-bed elevation, analgesia-sedation, glucose and temperature management; antiseizure drugs only for clinical seizures (not prophylactic); intermittent pneumatic compression for VTE prophylaxis, low-dose pharmacologic prophylaxis once stable, ICP lowering: Mass effect/herniation signs: osmotherapy (mannitol or hypertonic saline) with neurosurgical assessment）

Related tools

Other tools

🧠 GCS 🧠 ABCD² 🧠 NIHSS 🧠 mRS